XENOBIOTIC-METABOLIZING ENZYME EXPRESSION IN COLONIC NEOPLASIA

被引:65
作者
MCKAY, JA
MURRAY, GI
WEAVER, RJ
EWEN, SWB
MELVIN, WT
BURKE, MD
机构
[1] UNIV ABERDEEN, DEPT PATHOL, ABERDEEN AB9 2ZD, SCOTLAND
[2] UNIV ABERDEEN, DEPT BIOMED SCI, ABERDEEN AB9 2ZD, SCOTLAND
[3] UNIV ABERDEEN, DEPT MOLEC & CELL BIOL, ABERDEEN AB9 2ZD, SCOTLAND
关键词
D O I
10.1136/gut.34.9.1234
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The cytochrome P450, epoxide hydrolase, and glutathione S-transferase enzyme families play an important part in the metabolism of many carcinogens and anti-cancer drugs. The expression of two forms of cytochrome P450 (P450 IA and P450 3A), epoxide hydrolase and of the alpha, mu, and pi forms of glutathione S-transferase in normal colon, colonic adenomas, and adenocarcinoma of the colon were studied by immunohistochemistry. This allowed the precise cellular site and distribution of each enzyme to be determined. Expression of all the xenobiotic metabolising enzymes studied was almost wholly confined to the epithelial cells, whether in normal, adenoma or carcinoma samples, except that cytochrome P450 3A was also identified in mast cells and glutathione S-transferase pi was also present in chronic inflammatory cells. Cytochrome P450 was present in only a small proportion of normal colon samples, whereas epoxide hydrolase and glutathione S-transferase mu were identified in about half, and glutathione S-transferase alpha and pi in most normal samples. By contrast all the enzyme forms studied were expressed in virtually all adenomas and in over half the carcinomas. These results suggest that cytochrome P450 IA and cytochrome P450 3A are more specific markers of colonic neoplasia than epoxide hydrolase or glutathione S-transferases alpha, mu, and pi.
引用
收藏
页码:1234 / 1239
页数:6
相关论文
共 28 条
[1]   THE ROLE OF GLUTATHIONE-DEPENDENT ENZYMES IN DRUG-RESISTANCE [J].
BLACK, SM ;
WOLF, CR .
PHARMACOLOGY & THERAPEUTICS, 1991, 51 (01) :139-154
[2]   GENETIC-HETEROGENEITY OF THE HUMAN GLUTATHIONE TRANSFERASES - A COMPLEX OF GENE FAMILIES [J].
BOARD, P ;
COGGAN, M ;
JOHNSTON, P ;
ROSS, V ;
SUZUKI, T ;
WEBB, G .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :357-369
[3]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[4]  
DEWAZIERS I, 1991, CARCINOGENESIS, V12, P905
[5]   MOLECULAR-GENETICS OF THE P-450 SUPERFAMILY [J].
GONZALEZ, FJ .
PHARMACOLOGY & THERAPEUTICS, 1990, 45 (01) :1-38
[6]   DRUG-METABOLISM IN CARCINOGENESIS AND CANCER-CHEMOTHERAPY [J].
GRAHAM, MA ;
RILEY, RJ ;
KERR, DJ .
PHARMACOLOGY & THERAPEUTICS, 1991, 51 (02) :275-289
[7]  
GUENGERICH FP, 1988, CANCER RES, V48, P2946
[8]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407
[9]   CYTOSOLIC AND MICROSOMAL GLUTATHIONE S-TRANSFERASE ISOENZYMES IN NORMAL HUMAN-LIVER AND INTESTINAL EPITHELIUM [J].
HAYES, PC ;
HARRISON, DJ ;
BOUCHIER, IAD ;
MCLELLAN, LI ;
HAYES, JD .
GUT, 1989, 30 (06) :854-859
[10]   BILE-FLOW AND COLON CANCER [J].
HILL, MJ .
MUTATION RESEARCH, 1990, 238 (03) :313-320